A homogalacturonan from Lonicera japonica Thunb. disrupts angiogenesis via epidermal growth factor receptor and Delta-like 4 associated signaling

Glycoconj J. 2022 Dec;39(6):725-735. doi: 10.1007/s10719-022-10088-2. Epub 2022 Oct 28.

Abstract

A homogeneous polysaccharide named as LJW2F2 was extracted and purified from the flowers of Lonicera japonica Thunb. Structural characteristic indicated that LJW2F2 was a homogalacturonan composed of α-1,4-D-galacturonic acid with a molecular weight of 7.2 kDa. Previous investigation suggested that homogalacturonan might impede angiogenesis, however the mechanism is still vague. Here we reported that LJW2F2 significantly disrupted capillary-like tube formation of human microvascular endothelia cells (HMEC-1) on matrigel as well as the cells migration. Mechanism study revealed that LJW2F2 might inactivate phosphorylation of epidermal growth factor receptor (EGFR), subsequently suppress Raf, mitogen-activated protein kinase (MEK) and extracellular-related kinase (ERK) phosphorylation. Moreover, LJW2F2 markedly decreased the expression of Notch1 and Delta-like ligand 4 (Dll4). Therefore, our results suggested that LJW2F2 might be a potential angiogenesis inhibitor via disturbing multiple signaling pathways.

Keywords: Angiogenesis; Dll4/Notch1 signaling; EGFR/Raf/MEK/ERK signaling cascade; Homogalacturonan; Lonicera japonica.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ErbB Receptors / analysis
  • Flowers / chemistry
  • Humans
  • Lonicera* / chemistry
  • Polysaccharides / chemistry
  • Signal Transduction

Substances

  • ErbB Receptors
  • Polysaccharides